MALMO, Sweden and LOUVAIN-LA-NEUVE, Belgium, July 30, 2018 /PRNewswire/ -- DIAsource ImmunoAssays to assume production and sales of RIA product portfolio and the Neolisa™ ELISA product. Svar Life Science signs strategic agreement to transfer the portfolio of radioimmunoassays...
from PR Newswire: //https://ift.tt/2Oun9sH
No comments:
Post a Comment